🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

And we're off! The Interprofessional Session at #IUCLS2025 kicks off with a mini symposium on #HRQOL and symptom management with Andrew M. Evens, DO, MBA, MSc. Let's aim to improve patient outcomes!

Our second mini symposium for the Interprofessional Session at #IUCLS2025 is focused on novel therapies in #lymphoma. Find out how will CELMoDs, BTK degraders, and novel T-cell engagers will change the landscape of lymphoma treatement with Soni Smith MD and Nirav Shah.

And now our General Session kicks off at #IUCLS2025 with a mini symposium on diagnostics in lymphoma. Hear didactic and case-based discussions on using genomic testing and next generation hematopathology to impact diagnosis and treatment of #lymphoma. #lysms

#DLBCL is the most common subtype of NHL in the US. We are discussing incorporating novel ADCs in frontline therapy, optimal use of CAR T-cells and bispecifics, and caring for frail/older patients with this malignancy at the mini symposium on DLBCL. #IUCLS2025

Good morning from Chicago! We kick off day 2 at #IUCLS2025 by discussing the challenges and opportunities of globalizing #lymphoma research with Dr Luis Malpica Castillo from MD Anderson Cancer Center.

What is the role of BTK inhibitors, cellular therapy, and transplant for patients with #MCL? Find out at our mini symposium on mantle cell lymphoma with Tycel Phillips Lori Leslie and Tim Fenske #IUCLS2025

The care of #CLL has transformed dramatically with the advent of targeted therapies. Hear Deborah Stephens approach to caring for treatment-naive patients with this malignancy at #IUCLS2025.

Time for you to decide our duels in lymphoma! What do you think is the optimal approach to treating newly diagnosed #Hodgkin lymphoma?

What is your preferred therapy for patients with relapsed #follicular lymphoma?

The Keynote Presentation at #IUCLS2025 is Dr Nancy Bartlett from Siteman Cancer Center sharing her thoughts on best strategies on prioritizing #clinicalresearch while also balancing a clinical practice.

Join us for Resectability in the Era of Neoadjuvant/Periadjuvant Therapy, a symposium exploring the latest clinical data on resectability & the evolving role of neoadjuvant/perioperative therapy in early-stage #NSCLC. Register Now: loom.ly/a6QfUlc #AATS2025

Join us for Resectability in the Era of Neoadjuvant/Periadjuvant Therapy, a symposium exploring the latest clinical data on resectability & the evolving role of neoadjuvant/perioperative therapy in early-stage #NSCLC. Register Now: loom.ly/a6QfUlc #AATS2025

Join us for a 1-hour program discussing recent clinical data impacting the determination of resectability and the evolving role of neoadjuvant/perioperative therapy in the management of early-stage #NSCLC on May 4 at 12:00 PM. Register today: loom.ly/a6QfUlc #AATS2025

🌟Know an outstanding #hematologist or medical #oncologist who's demonstrating exceptional leadership? 🏆 Nominate her for the prestigious Rising Star or Woman Oncologist of the Year Awards: loom.ly/i-w7mb4 Let's honor her contributions together! #LEAD2025